B of A Securities maintains Buy rating, raises PT to $7 for Sana Biotechnology.

martes, 6 de enero de 2026, 12:16 pm ET1 min de lectura
SANA--

B of A Securities maintains Buy rating, raises PT to $7 for Sana Biotechnology.

B of A Securities maintains Buy rating, raises PT to $7 for Sana Biotechnology.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios